化疗可以改善骨肉瘤患者的预后吗? 一个系统的审查和元分析
1Division of Oral and Maxillofacial Surgery, Faculty of Dentistry and Graduate School of Medical and Dental Sciences, Niigata University, Niigata, Japan.
International journal of oral and maxillofacial surgery
|September 30, 2025
概括
化疗在与手术相结合时,显著改善了高度骨肉瘤 (JOS) 的生存结果. 这一发现为完善这种罕见的骨癌的治疗方案提供了宝贵的见解.
科学领域:
- 在瘤学瘤学.
- 手术瘤学手术瘤学
- 医学研究 医学研究
背景情况:
- 骨肉瘤 (JOS) 是一种罕见的恶性瘤,局部复发率高.
- 化疗在JOS治疗中的有效性仍然是争论的主题.
- 现有的研究缺乏对化疗对JOS生存结果的影响的全面分析.
研究的目的:
- 系统地评估化疗对骨肉瘤患者存活期的影响.
- 确定影响JOS生存的预后因素.
- 为JOS治疗方案提供基于证据的建议.
主要方法:
- 在PubMed,Embase和谷歌学者 (1990-2024) 中进行了系统的文献搜索.
- 包括的研究报告了组织学证实JOS的生存数据.
- 使用卡普兰-梅尔分析和考克斯回归来评估生存率和预后因素.
主要成果:
- 这项研究分析了20项研究中的330名患者的数据.
- 五年和10年整体生存率分别为37.1%和10.5%.
- 与单独手术相比,接受手术加化疗的高度JOS患者的生存率有所改善 (HR 0.500,P=0.035).
- 更糟糕的预后因素包括年龄 (≥40),积极的手术边缘和瘤大小 (≥5厘米).
结论:
- 化疗在与手术结合使用时,对高度骨肉瘤具有显著的生存益处.
- 年龄,手术边缘状况和瘤大小是JOS的关键预后指标.
- 这些发现支持将化疗纳入高度JOS的治疗策略,以改善患者的治疗结果.
相关概念视频
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Cancer Survival Analysis
648
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
648
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K


